Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000268632

Medchemexpress LLC Upadacitinib-15N,d2 | 100.0% | 383.37 | C17H17D2F3N515NO | 1mg
SDP

Catalog No. 5000268632
Encompass_Preferred

Upadacitinib-15N d2 (ABT-494-15N d2) is the deuterium-labeled Upadacitinib (HY-19569) Upadacitinib-15N d2 (ABT-494) is a potent orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50 43 nM) Upadacitinib-15N d2 (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific relevant cytokines Upadacitinib-15N d2 (ABT-494) can be used for several autoimmune disorders research[1][2]

Catalog No. 50-002-68632 Supplier Medchemexpress LLC Supplier No. HYW7278791MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Upadacitinib-15N d2 (ABT-494-15N d2) is the deuterium-labeled Upadacitinib (HY-19569) Upadacitinib-15N d2 (ABT-494) is a potent orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50 43 nM) Upadacitinib-15N d2 (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific relevant cytokines Upadacitinib-15N d2 (ABT-494) can be used for several autoimmune disorders research[1][2]

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.